| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |